Newsroom

News

Viruses are mostly encountered as pathogens. However, virus-based vaccination platforms can also help to provide protection from different diseases. In a mouse model, researchers from the Helmholtz Centre for Infection Research (HZI) in Braunschweig together with national and international partners including the German Center for Infection Research (DZIF), the German Primate Center – Leibniz Institute for Primate Research (DPZ), the Technische Universität Braunschweig and the University of Rijeka, Croatia, have developed a novel cytomegalovirus-based vaccine against different respiratory viruses. A single dose of the vaccine that consists of a cytomegalovirus that incorporates genes from coronavirus or influenza A efficiently protected mice from the respiratory infections. The results on the vaccine candidate, which is not yet market-ready, were published in the journal Cellular & Molecular Immunity.

17.01.2022

HZI Campus

News

Principal Investigator Mathias Munschauer aims to better understand SARS-CoV-2. He now receives funding of 1.5 million euros for his research project “COVIDecode” from the European Research Council (ERC). Munschauer is the third scientist at the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg to be awarded an ERC grant.

10.01.2022

HIRI

News

Silke Tannapfel, former Administrative Director, will leave the Helmholtz Centre for Infection Research (HZI) in Braunschweig on 31 December 2021 to take on new professional challenges as Ministerial Director in the Hessian Ministry of Higher Education, Research and the Arts. Elisabeth Gerndt, authorised signatory and head of the Finance and Controlling Department at the HZI, is taking over the position of acting Administrative Director.

15.12.2021

HZI Campus

News

The increasing spread of resistant germs means that formerly highly effective antibiotics are often not successful anymore in treating infectious diseases. To counteract this development, the team led by Prof. Anna Hirsch from the Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) has developed new drug candidates that are able to render one of the most important hospital germs harmless. The researchers have published their results in the journal Angewandte Chemie.

14.12.2021

HIPS

News

Researchers from the Helmholtz Institute for RNA-based Infection Research (HIRI) in Würzburg and the University of Cambridge have revealed the molecular details of a genetic switch through their work on the 2A protein of cardioviruses. Using a new RNA-binding fold, the 2A protein activates a process called ribosomal frameshifting, which allows the virus to replicate more efficiently. This event represents an essential switch in the life cycle of the virus as well as presenting a viral Achilles' heel that could be targeted by future RNA-based therapies. The new findings have been published in the journal Nature Communications. The HIRI is a joint venture of the Helmholtz Centre for Infection Research (HZI) in Braunschweig and the Julius Maximilian University of Würzburg (JMU)

14.12.2021

HIRI

Strukturmodel des Spike-Proteins von SARS-CoV-2.

News

The rapid expansion of the Omicron variant has taken the international medical and scientific community by surprise. After infection or vaccination against the coronavirus, our bodies produce antibodies that play a key role in protecting us against COVID-19. While early reports indicate that numerous mutations on the virus surface of the Omicron variant may allow the virus to escape this immune recognition, it is unclear if the mutations improve binding to cell surface receptors and thus facilitate the infection.

13.12.2021

HZI Campus

Back to the first page
...
51
52
53
54
...
153

HZI in the media

... späten 1990ern hob sie der am Saarbrücker Helmholtz-Institut für Pharmazeutische Forschung Saarland (HIPS) tätige ...

08.03.2026

Saarbrücker Zeitung

European institutions, including Germany’s Helmholtz Institute for RNA-based Infection Research, Helmholtz Center for Infection Research,

06.03.2026

Clinical Lab Products

Die Zellen kontrollieren die Reaktion des Immunsystems und verhindern Schäden durch Selbstangriffe. Forschende arbeiten daran, sie zur Therapie einzusetzen.

05.03.2026

NDR Norddeutscher Rundfunk

Nachwuchsgruppe „Nanoinfektionsbiologie“ am HZI. Diese Lücke soll das Projekt ONEMUC (Respiratorischer Mukus als One Health-Schnittstelle) ...

03.03.2026

DeutschesGesundheitsPortal

Hochschule Hannover (MHH) und des Helmholz-Zentrums für Infektionsforschung (HZI) erforschen im Rahmen des Projektes StopPSC ( ...

03.03.2026

Biermann Medizin

Mdisk, stock.adobe.com

Braunschweig – Das Helmholtz-Zentrum für Infektionsforschung ( HZI ) in Braunschweig erhält für sein ...

03.03.2026

Deutsches Ärzteblatt

Josef Penninger, wissenschaftlicher Geschäftsführer des Helmholtz Zentrums für Infektionsforschung in Braunschweig und Professor für

01.03.2026

EUROPE SAYS

... Körperzellen. Damit tragen wir, wie das Helmholtz-Zentrum für Infektionsforschung (HZI) es treffend beschreibt, unseren „ganz ...

27.02.2026

MSN Deutschland

Eine Impfung bringt das Immunsystem in Stellung, bevor der echte Erreger kommt. Erfahren Sie, wie ...

26.02.2026

Apotheken Umschau

Livia V. Patrono, one of the senior authors at the Helmholtz Institute for One Health (HIOH) in Germany, said in a statement .

The research

25.02.2026

IFL Science

says Livia Patrono, a veterinarian and disease ecologist at Helmholtz Institute for One Health in Greifswald, Germany. In 2012, an infected

24.02.2026

Science News

... Dr. rer. nat. Jakob Wirbel vom Helmholtz-Zentrum für Infektionsforschung (Braunschweig). Das Experiment aus Stanford sei ...

20.02.2026

Deutsches Ärzteblatt

Register now for the HZI-Newsletter

and stay up to date!

Email address *

We use rapidmail to send our newsletter. I agree that my data entered here will be transmitted to rapidmail. I have taken note of the HZI's privacy policy and have been informed of my rights.